Smoking and amyotrophic lateral sclerosis: A mendelian randomization study.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 30786056.
- Also identified by DOI 10.1002/ana.25443.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this study, we examined the potential causal effect of smoking on amyotrophic lateral sclerosis (ALS) using the Project MinE data involving 12,577 patients with ALS and 23,475 controls in a Mendelian randomization (MR) framework. The MR approach has the potential to investigate a causal relationship between a risk factor and a disease, avoiding confounding and information bias that often present in conventional epidemiological studies. We found that smokers had a higher risk of ALS compared to never smokers. Our study thus provides evidence for a causal relationship between smoking and ALS. Ann Neurol 2019;85:482-484.
Medical subject headings
- Amyotrophic Lateral Sclerosis
- Mendelian Randomization Analysis
- Polymorphism, Single Nucleotide
- Smoking